April 22 (Reuters) - Cochlear shares crashed nearly 41% on Wednesday in a record daily fall, after the Australian hearing implants maker slashed its forecast for annual earnings, citing weak trading ...

A major Australian medical company has suffered a $4.4b wipeout after slashing its earnings forecast, which drove its share ...

The hearing implant maker’s shares cratered to the lowest level since April 2016 amid the Middle East conflict and plunging ...

The world’s gone cold on treating hearing loss and Australia’s Cochlear is bearing the brunt. Cochlear isn’t selling hearing ...

SYDNEY--Cochlear shares are on course for their worst day since the hearing-implant maker went public in 1995, tumbling 40% after the Australian company slashed its annual profit guidance on weak U.S.

Cochlear’s shares have collapsed after the hearing implants behemoth again downgraded profit guidance by up to $170m on ...

Cochlear Ltd. shares moved sharply lower in early Sydney trading on Wednesday, falling as much as 39% and marking the company ...

One of Australia's biggest companies, Cochlear, has rattled investors by slashing its profit outlook, while the broader market drops. Follow live.

The medical device manufacturer has delivered a bitter pill for shareholders. The post Why are Cochlear shares down 36% today ...

All 56 Enrolled Subjects Have Been Through Their Activation Visit Firming Up Study TimelineWhite Bear Lake, Minnesota--(Newsfile Corp. - April 22, 2026) - Envoy Medical® Inc. (NASDAQ: COCH) ("Envoy ...

Cochlear, an Australian hearing implant manufacturer, has slashed its 2026 earnings forecast due to the Middle East conflict, resulting in a nearly 39% drop in share value. The turmoil has affected ...

Cochlear Ltd has updated its trading performance, reducing its FY26 earnings guidance to A$290-330 million. The company anticipates a 2-6% sales growth in the second half, in constant currency.